18F-fluoride positron emission tomography/computed tomography and bone scintigraphy for diagnosis of bone metastases in newly diagnosed, high-risk prostate cancer patients: study protocol for a multicentre, diagnostic test accuracy study

被引：0
作者：
Randi F. Fonager
Helle D. Zacho
Niels C. Langkilde
Lars J. Petersen
机构：
[1] Aalborg University Hospital,Department of Nuclear Medicine, Clinical Cancer Research Center
[2] Aalborg University Hospital,Department of Urology
[3] Aalborg University,Department of Clinical Medicine
来源：
BMC Cancer | / 16卷
关键词：
Positron emission tomography/computed tomography; F-fluoride; Planar bone scintigraphy; Bone metastases; Prostate cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 141 条
  • [1] Damber JE(2008)Prostate cancer Lancet 371 1710-1721
  • [2] Aus G(2005)Osteoblasts in prostate cancer metastasis to bone Nat Rev Cancer 5 21-28
  • [3] Logothetis CJ(2010)Skeletal related events, bone metastasis and survival of prostate cancer: a population based cohort study in Denmark (1999 to 2007) J Urol 184 162-167
  • [4] Lin SH(2010)The 2010 NCCN clinical practice guidelines in oncology on prostate cancer J Natl Compr Canc Netw 8 145-71
  • [5] Nørgaard M(2011)EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease Eur Urol 59 61-106
  • [6] Jensen AO(2014)Prostate cancer: summary of updated NICE guidance BMJ 348 f7524-31
  • [7] Jacobsen JB(2003)Bone scintigraphy: procedure guidelines for tumour imaging Eur J Nucl Med Mol Imaging 30 BP99-67
  • [8] Cetin K(2014)Prospective multicenter study of bone scintigraphy in consecutive patients with newly diagnosed prostate cancer Clin Nucl Med 39 26-945
  • [9] Fryzek JP(2014)Whole-body SPECT/CT for bone scintigraphy: diagnostic value and effect on patient management in oncological patients Eur J Nucl Med Mol Imaging 41 59-599
  • [10] Sørensen HT(2013)A literature review of 18F-fluoride PET/CT and 18F-choline or 11C-choline PET/CT for detection of bone metastases in patients with prostate cancer Nucl Med Commun 34 935-49
12345678910